About: No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS)
Creator	Maxwell, Cynthia Sermer, Mathew Fan, Kin Mcgeer, Alison Tai, Young
Source	Elsevier; Medline; PMC
abstract	OBJECTIVE: This document summarizes the limited experience of SARS in pregnancy and suggests guidelines for management. OUTCOMES: Cases reported from Asia suggest that maternal and fetal outcomes are worsened by SARS during pregnancy. EVIDENCE: Medline was searched for relevant articles published in English from 2000 to 2007. Case reports were reviewed and expert opinion sought. VALUES: Recommendations were made according to the guidelines developed by the Canadian Task Force on Preventive Health Care. SPONSORS: The Society of Obstetricians and Gynaecologists of Canada. RECOMMENDATIONS: 1. All hospitals should have infection control systems in place to ensure that alerts regarding changes in exposure risk factors for SARS or other potentially serious communicable diseases are conveyed promptly to clinical units, including the labour and delivery unit (III-C). 2. At times of SARS outbreaks, all pregnant patients being assessed or admitted to the hospital should be screened for symptoms of and risk factors for SARS (III-C). 3. Upon arrival in the labour triage unit, pregnant patients with suspected and probable SARS should be placed in a negative pressure isolation room with at least 6 air exchanges per hour. All labour and delivery units caring for suspected and probable SARS should have available at least one room in which patients can safely labour and deliver while in need of airborne isolation (III-C). 4. If possible, labour and delivery (including operative delivery or Caesarean section) should be managed in a designated negative pressure isolation room, by designated personnel with specialized infection control preparation and protective gear (III-C). 5. Either regional or general anaesthesia may be appropriate for delivery of patients with SARS (III-C). 6. Neonates of mothers with SARS should be isolated in a designated unit until the infant has been well for 10 days, or until the mother’s period of isolation is complete. The mother should not breastfeed during this period (III-C). 7. A multidisciplinary team, consisting of obstetricians, nurses, pediatricians, infection control specialists, respiratory therapists, and anaesthesiologists, should be identified in each unit and be responsible for the unit organization and implementation of SARS management protocols (III-C). 8. Staff caring for pregnant SARS patients should not care for other pregnant patients. Staff caring for pregnant SARS patients should be actively monitored for fever and other symptoms of SARS. Such individuals should not work in the presence of any SARS symptoms within 10 days of exposure to a SARS patient (III-C). 9. All health care personnel, trainees, and support staff should be trained in infection control management and containment to prevent spread of the SARS virus (III-A). 10. Regional health authorities in conjunction with hospital staff should consider designating specific facilities or health care units, including primary, secondary, or tertiary health care centres, to care for patients with SARS or similar illnesses (III-A).
has issue date	2017-07-18(xsd:dateTime)
bibo:doi	10.1016/j.jogc.2017.04.024
bibo:pmid	28729104
has license	no-cc
sha1sum (hex)	6d080e8fd8bfa4707b4bd47e3100486acab985e4
schema:url	https://doi.org/10.1016/j.jogc.2017.04.024
resource representing a document's title	No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS)
has PubMed Central identifier	PMC7105038
has PubMed identifier	28729104
schema:publication	J Obstet Gynaecol Can
resource representing a document's body	covid:6d080e8fd8bfa4707b4bd47e3100486acab985e4#body_text
is schema:about of	named entity 'With' named entity 'PROBABLE SEVERE ACUTE RESPIRATORY SYNDROME' named entity 'MOTHERS' named entity 'This' named entity 'Objective' named entity 'limited' named entity 'Neonates' named entity 'No. 225' named entity 'Neonates' named entity 'Obstetric' named entity 'negative pressure' named entity 'Asian flu' named entity 'potentially infectious' named entity 'mechanical ventilation' named entity 'bacterial pneumonia' named entity 'pneumonia' named entity 'antibiotics' named entity 'neonatal' named entity 'negative air pressure' named entity 'ribavirin' named entity 'multi-drug resistant' named entity 'SARS' named entity 'SARS' named entity 'SARS' named entity 'infection control' named entity 'postnatal' named entity 'SARS' named entity 'postpartum' named entity 'anaesthetic' named entity 'epidemic' named entity 'SARS' named entity 'infection control' named entity 'ventilatory support' named entity 'N95 masks' named entity 'SARS' named entity 'Neonates' named entity 'corticosteroids' named entity 'airway' named entity 'epidemic' named entity 'infection control' named entity 'infection' named entity 'breastfed' named entity 'early delivery' named entity 'Vietnam' named entity 'SARS' named entity 'virus' named entity 'Hypoxia' named entity 'SARS' named entity 'SARS' named entity 'epidural' named entity 'SARS' named entity 'umbilical cord' named entity 'Caesarean section' named entity 'Infection control' named entity 'mechanical ventilation' named entity 'Canadian' named entity 'general anaesthesia' named entity 'uterine' named entity 'isolation ward' named entity 'negative pressure ventilation' named entity 'SARS' named entity 'HIV' named entity 'gynaecological' named entity 'non-pregnant' named entity 'evere' named entity 'neonate' named entity 'diabetes' named entity 'Hong Kong' named entity 'negative pressure' named entity 'obstetric' named entity 'early pregnancy loss' named entity 'neonatal' named entity 'electronic mail' named entity 'SARS' named entity 'ribavirin' named entity 'SARS' named entity 'delivery room'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software